Pregnancy and childbirth are usually filled with anticipation and hope. Modern obstetrics has dramatically improved the ...

Adding a high dose of erythropoietin to therapeutic hypothermia did not reduce rates of death or disability in infants with neonatal hypoxic ischemic encephalopathy (HIE), a phase III randomized trial ...

Brain injuries are a leading cause of death and long-term disability in infants. Among the most common is neonatal hypoxic-ischemic encephalopathy (HIE), which affects one to three in 1,000 live ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby’s body temperature—called therapeutic hypothermia—is often used ...

Hypoxic-Ischemic Encephalopathy (HIE) is a critical and severe form of neonatal brain injury. It occurs when a newborn suffers from oxygen deprivation and restricted blood flow (ischemia) either ...

Diffusion-weighted MRI can help predict severe neurological outcomes in infants, enabling early diagnosis of cerebral palsy and delays from hypoxic brain injury Diffusion-weighted MRI will be the ...

Researchers from Chiesi Farmaceutici SpA published new clinical data for CHF-6467, a recombinant modified form of human nerve growth factor (NGF), being evaluated for the treatment of neonatal hypoxic ...